Diligence memo · auto-generated · as of July 2, 2026

HealthMed Corp

HealthMed Corp looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

HealthMed Corp operates in Pharmaceuticals, based in NEWARK.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

HealthMed Corp has raised $3.5M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $2.0M on —.

Valuation (modeled)modeled

Provath models HealthMed Corp at approximately $3.4M (range $1.5M–$5.2M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.07× the median modeled value of Seed Pharmaceuticals companies (335 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

No dated round to assess.

The last round stepped up 1.0× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 36% of Pharmaceuticals peers (1613 compared).

Modeled value ranks above 6% of those peers.

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.